This codelist contains oxycodone formulations which may be given subcutaneously. This is based on the list for ["Priority medicines for palliative and end of life care during a pandemic"](https://apmonline.org/wp-content/uploads/2020/04/priority-meds-for-end-of-life-care-290420-final-2.pdf)

Identifies codes which refer to Paget's disease of the bone.

This codelist aims to identify people who have a parental history of hip fractures.

This codelist contains drugs which are likely to contraindicate the use of Paxlovid (nirmatrelvir/ritonavir). This list is a refinement of previous "do not co-administer" lists to filter out drugs where mitigation strategies may be employed - e.g. withholding the drug during Paxlovid therapy.
See [GitHub issue](https://github.com/opensafely/codelist-development/issues/266) for full details.

A codelist to identify all prescribing of Paxlovid (Nirmatrelvir with Ritonavir).

User requirements
Codelist needed to return all recorded prescriptions of Paxlovid in primary care records.

The PEFR_COD cluster in the asthma reference set taken from the Primary Care Domain Reference Set Portal, published by NHS Digital on 2021-12-21.

dm+d codelist for penicillamine

This codelist aims to identify adult patients who have peripheral arterial disease (PAD) where an atherosclerotic pathology exists.

The definition of PAD in this codelist is not limited to limb disease. It includes pathologies affecting vessels not existing within (or primarily supplying) the coronary, cerebral, or retinal circulation. This is intended to provide coverage of all cardiovascular atherosclerotic disease when combined with separate codelists for IHD and cerebrovascular disease.

Codes indicating a diagnosis of a permanent immunosuppression excluding HIV, and including genetic causes of immunosuppression

Automatically-generated equivalent of [Permanent Immunosuppression](/codelist/opensafely/permanent-immunosuppression/)

Identifies codes which indicate a definite loss of childbearing potential which cannot plausibly be restored. The scope of the codelist is limited to female patients.

### User requirements
This codelist is used to identify supply of any medication included in the Pharmacy First Patient Group Directions for treatment of acute otitis media.

### Sensitivity versus specificity

##### User requirements
This codelist is used to identify supply of any medication included in the Pharmacy First Patient Group Directions for treatment of acute otitis media.

##### Sensitivity versus specificity

This codelist is used to identify supply of any medication included in the Pharmacy First Patient Group Directions for treatment of acute otitis media.

It is specific to only the strength/formulations included in the PGDs for acute otitis media (including both brands and generics).